Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates

Journal of Virology

Volumn 74, Issue 19, 2000, Pages 8922-8929

  Schmidt, A C ^a   McAuliffe, J M ^a   Huang, A ^a   Surman, S R ^a   Bailly, J E ^a   Elkins, W R ^a   Collins, P L ^a   Murphy, B R ^a   Skiadopoulos, M H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; HYBRID PROTEIN; RECOMBINANT PARAINFLUENZA VIRUS TYPE 3 PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; GENETIC RECOMBINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; RHESUS MONKEY; SEQUENCE ANALYSIS; VIRUS REPLICATION;

ANIMAL; CATTLE; CELL LINE; HN PROTEIN; HUMAN; PRIMATES; RESPIROVIRUS; VIRAL FUSION PROTEINS; VIRUS REPLICATION;

EID: 0033807599     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.19.8922-8929.2000     Document Type: Article

References (44)

1. A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates
2. Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated in primates
3. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host range and evaluation as a live-attenuated HRSV vaccine
4. Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees
5. Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors
6. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers
7. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants
8. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge
9. Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: Nucleotide sequence analysis of variants selected with monoclonal antibodies
10. Parainfluenza viruses
11. Receptor specificity in human, avian, and equine H2 and H3 influenza vires isolates
12. Current approaches to the development of vaccines against disease caused by respiratory syncytial vires (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development
13. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike
14. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies
15. Recovery of infectious human parainfluenza virus type 3 from cDNA
16. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates
17. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a novel method for immunization against measles virus and PIV3 in early infancy
18. A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees
19. Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus
20. Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys
21. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses
22. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one
23. A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A is unable to process the precursor fusion glycoprotein of Newcastle disease virus
24. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential
25. An update on the 'Jennerian' and modified 'Jennerian' approach to vaccination of infants and young children against rotavirus diarrhea
26. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants
27. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children
28. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children
29. Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses
30. Antigenic variation of human and bovine parainfluenza virus type 3 strains
31. Inhibition of the neuraminidase of paramyxoviruses by halide ions: A possible means of modulating the two activities of the HN protein
32. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4
33. Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers
34. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: Specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface
35. Interaction of Sendai viral F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cells
36. Molecular evolution of influenza viruses
37. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses
38. Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses
39. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers
40. Applied nonparametric statistical methods
41. Functional interaction of paramyxovirus glycoproteins: Identification of a domain in Sendai virus HN which promotes cell fusion
42. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge
43. Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs
44. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells